Global biotechnology reagents market is expected to rise from its initial estimated value of USD 65.82 billion in 2018 to an estimated value of USD 118.53 billion by 2026, registering a CAGR of 7.63% in the forecast period of 2019-2026. This rise in market value can be attributed to the significant investments by private players in biotechnology.
Get Free Sample of Global Market Information: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biotechnology-reagents-market
Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, genetics, molecular biology, diagnosis, immunology and bioscience. Biotechnology reagents comprises of technologies such as cell culture, spectrometry, IVD, PCR, chromatography, expression and transfection, flow cytometry, and electrophoresis, and find their application in areas such as immune phenotyping, fluorescent microscopy, DNA analysis and cell cycle analysis.
According to the Innovative Research, in U.S., around 65% of biotech companies are involved in drug developed with an intention to serve them for medical purposes and pharmaceuticals. Growing number of biotechnology firms in various countries is expected to act as a driver for the market growth.
- Increasing interest in stem cell research
- Increasing usage of reagents in commercial and research fields
- Stringent government regulations for the approval of reagents
- High cost of reagents will act as a restraint for the market
Key Market Competitors:
Few of the major competitors currently working in the biotechnology reagents market are Abbott, Agilent Technologies Inc., Danaher, BD, Bio-Rad Laboratories Inc., General Electric, bioMérieux SA, LONZA, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hoefer, Inc., Meridian Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Promega Corporation, Quality Biological, Siemens AG, Bio-Techne, TAKARA HOLDINGS INC., Sysmex Corporation, Tosoh Corporation, WATERS, W. R. Grace & Co.-Conn., Ortho Clinical Diagnostics, Olympus Corporation and Fitzgerald Industries International among others.
Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-biotechnology-reagents-market
Key Developments in the Market:
- In March, 2019, Thermo Fisher acquired Brammer Bio for approximately $1.7 billion in cash. This acquisition is designed to gain buyer’s presence in gene therapy with the viral vector contract development and manufacturing organization (CDMO).
- In February 2019, Bio-techne signs a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics. This agreement will help both the companies to accelerate the development of molecular diagnostics in the Chinese market.
Segmentation: Global Biotechnology Reagents Market
- By Technology
- Life Sciences
- By Applications
- Protein Synthesis & Purification
- Gene Expression
- DNA & RNA Analysis
- Drug Testing
- By Geography
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East and Africa
Global biotechnology reagents market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biotechnology reagents market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biotechnology-reagents-market
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing firstname.lastname@example.org . We are content with our glorious 99.9 % client satisfying rate.